13
Cellular Immunodeficiency
Î Consider immediate consultation with a dermatologist familiar with
cutaneous manifestations of infection in patients with cellular immune
defects (eg, those with lymphoma, lymphocytic leukemia, recipients
of organ transplants, or those receiving immunosuppressive drugs
such as anti-tumor necrosis factors or certain monoclonal antibodies)
(WR-L).
Î Consider biopsy and surgical debridement early in the management of
these patients (WR-L).
Î Empiric antibiotics, antifungals and/or antivirals should be considered
in life-threatening situations (WR-M). The use of specific agents
should be decided with the input of the primary team, dermatology,
infectious disease and other consulting teams (SR-M).
